The art of choosing sound study endpoints

被引:5
作者
Hanson, Beate [1 ]
机构
[1] AO Clin Invest & Documentat, CH-8600 Dubendorf, Switzerland
来源
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED | 2008年 / 39卷 / 06期
关键词
clinical trials; outcome; function; quality of life;
D O I
10.1016/j.injury.2008.02.014
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The selection of appropriate endpoints is the key to successful clinical studies. The chosen primary outcome measure ultimately determines the required sample size, significantly affects trial Logistics, and establishes acceptance of results in the scientific community. Confirmatory statistics may only be conducted on the primary endpoint, white secondary endpoints are better analysed in an exploratory fashion. While investigators may prefer surrogates (e.g., radiographic results, laboratory markers) clinical trials should no longer be planned without addressing function or quality of life. Valid outcome tools (e.g., Short-Form 36) are needed to ensure comparability of findings to other studies. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:656 / 658
页数:3
相关论文
共 50 条
[21]   Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study [J].
Doody, Amy ;
Alfano, Lindsay ;
Diaz-Manera, Jordi ;
Lowes, Linda ;
Mozaffar, Tahseen ;
Mathews, Katherine D. ;
Weihl, Conrad C. ;
Wicklund, Matthew ;
Hung, Man ;
Statland, Jeffrey ;
Johnson, Nicholas E. .
BMC NEUROLOGY, 2024, 24 (01)
[22]   Optimal treatment allocation and study duration for trials with discrete-time survival endpoints [J].
Jozwiak, Katarzyna ;
Moerbeek, Mirjam .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2013, 143 (05) :971-982
[23]   Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study [J].
Amy Doody ;
Lindsay Alfano ;
Jordi Diaz-Manera ;
Linda Lowes ;
Tahseen Mozaffar ;
Katherine D. Mathews ;
Conrad C. Weihl ;
Matthew Wicklund ;
Man Hung ;
Jeffrey Statland ;
Nicholas E. Johnson .
BMC Neurology, 24
[24]   Cancer clinical trials with efficacy and toxicity endpoints: A simulation study to compare two nonparametric methods [J].
Letierce, Alexia ;
Tubert-Bitter, Pascale .
ADVANCES IN STATISTICAL METHODS FOR THE HEALTH SCIENCES: APPLICATIONS TO CANCER AND AIDS STUDIES, GENOME SEQUENCE ANALYSIS, AND SURVIVAL ANALYSIS, 2007, :335-+
[25]   Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints [J].
Do, Albert ;
Ilagan-Ying, Ysabel C. ;
Mehal, Wajahat Z. ;
Lim, Joseph K. .
EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (02) :125-134
[26]   Study duration prediction for clinical trials with time-to-event endpoints accounting for heterogeneous population [J].
Zhang, Hong ;
Pu, Jie ;
Deng, Shibing ;
Roychoudhury, Satrajit ;
Chu, Haitao ;
Robinson, Douglas .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2025,
[27]   Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials [J].
Ang, Joo Ern ;
Kaye, Stan ;
Banerji, Udai .
CURRENT DRUG TARGETS, 2012, 13 (12) :1525-1534
[28]   Index and Nonindex Pain Endpoints in Radiation Therapy for Painful Tumors: A Secondary Analysis of a Prospective Observational Study [J].
Saito, Tetsuo ;
Nakamura, Naoki ;
Murotani, Kenta ;
Shikama, Naoto ;
Takahashi, Takeo ;
Yorozu, Atsunori ;
Heianna, Joichi ;
Kubota, Hikaru ;
Tomitaka, Etsushi ;
Toya, Ryo ;
Yamaguchi, Kohsei ;
Oya, Natsuo .
ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (06) :1118-1125
[29]   Probability of Study Success (PrSS) Evaluation Based on Multiple Endpoints in Late Phase Oncology Drug Development [J].
Zhang, Zhen ;
Lin, Yong ;
Liu, Jingyi .
STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (03) :675-688
[30]   Art therapy in palliative care: A qualitative study [J].
Rhondali, Wadih ;
Chirac, Anne ;
Filbet, Marilene .
MEDECINE PALLIATIVE, 2013, 12 (06) :279-285